1 tracked superinvestor hold DAMORA THERAPEUTICS INC (DMRA), worth $60M combined, led by Andreas Halvorsen. Smart money is accumulating DMRA as of the latest 13F filings.
Current price
$30.78
+722.2%
1Y
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq…
Market cap
$1.5B
P/E
-6.37
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$40
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$60M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating DMRA: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
DAMORA THERAPEUTICS INC (DMRA) is held by 1 tracked funds worth $60M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Andreas Halvorsen), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.2% | $60M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own DMRA?
1 tracked funds hold DAMORA THERAPEUTICS INC (DMRA), the largest being Andreas Halvorsen (Viking Global Investors) at 0.2% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling DMRA?
In the most recent 13F quarter, 1 tracked fund added or opened DMRA and 0 trimmed it, including 1 brand-new position.
How much DMRA do tracked funds hold?
Combined disclosed long exposure to DMRA across tracked superinvestors is $60M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.